[1]
|
Gunaratne, P.H., Pan, Y., Rao, A.K., Lin, C., Hernandez-Herrera, A., Liang, K., et al. (2019) Activating p53 Family Member TAp63: A Novel Therapeutic Strategy for Targeting p53-Altered Tumors. Cancer, 125, 2409-2422.
https://doi.org/10.1002/cncr.32053
|
[2]
|
Costanzo, A., Pediconi, N., Narcisi, A., Guerrieri, F., Belloni, L., Fausti, F., Botti, E. and Levrero, M. (2014) TP63 and TP73 in Cancer, an Unresolved “Family” Puzzle of Complexity, Re-dundancy and Hierarchy. FEBS Letters, 588, 2590-2599. https://doi.org/10.1016/j.febslet.2014.06.047
|
[3]
|
Gonfloni, S., Di Tella, L., Caldarola, S., Cannata, S.M., Klinger, F.G., Di Bartolomeo, C., et al. (2009) Inhibition of the c-Abl-TAp63 Pathway Protects Mouse Oocytes from Chemotherapy-Induced Death. Nature Medicine, 15, 1179-1185.
https://doi.org/10.1038/nm.2033
|
[4]
|
Yang, A., Kaghad, M., Wang, Y.M., Gillett, E., Fleming, M.D., Dötsch, V., et al. (1998) p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities. Molecular Cell, 2, 305-316. https://doi.org/10.1016/S1097-2765(00)80275-0
|
[5]
|
Murray-Zmijewski, F., Lane, D.P. and Bourdon, J.-C. (2006) P53/P63/P73 Isoforms: an Orchestra of Isoforms to Harmonise Cell Differentiation and Response to Stress. Cell Death & Differentiation, 13, 962-972.
https://doi.org/10.1038/sj.cdd.4401914
|
[6]
|
王建力, 陈莉, 王杜兰, 曹晓蕾. P63在皮肤鳞状细胞癌中的表达[J]. 南通医学院学报, 2001, 24(4): 339-340.
|
[7]
|
Sankaranarayanan, R., Swaminathan, R., Brenner, H., Chen, K., Chia, K.S., Chen, J.G, et al. (2010) Cancer Survival in Africa, Asia, and Central America: A Population-Based Study. The Lancet Oncology, 11, 165-173.
|
[8]
|
Small, W., Bacon, M.A., Bajaj, A., Chuang, L.T., Fisher, B.J., Harkenrider, M.M., et al. (2017) Cervical Cancer: A Global Health Crisis. Cancer, 123, 2404-2412. https://doi.org/10.1002/cncr.30667
|
[9]
|
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. https://doi.org/10.3322/caac.20107
|
[10]
|
Parkhurst, J.O. and Vulimiri, M. (2013) Cervical Cancer and the Global Health Agenda: Insights from Multiple Policy-Analysis Frameworks. Global Public Health, 8, 1093-1108. https://doi.org/10.1080/17441692.2013.850524
|
[11]
|
Deligeoroglou, E., Giannouli, A., Athanasopoulos, N., Karountzos, V., Vatopoulou, A., Dimopoulos, K., et al. (2013) HPV Infection: Immunological Aspects and Their Utility in Future Therapy. Infectious Diseases in Obstetrics and Gynecolog, 2013, Article ID: 540850. https://doi.org/10.1155/2013/540850
|
[12]
|
Mai, M., Huang, H., Reed, C., Qian, C., Smith, J.S., Alderete, B., et al. (1998) Genomic Organization and Mutation Analysis of p73 in Oligodendrogliomas with Chromosome 1 P-arm Dele-tions. Genomics, 51, 359-363.
https://doi.org/10.1006/geno.1998.5387
|
[13]
|
杨宇, 许庆, 张瑜. p63在宫颈癌中的研究进展[J]. 生命科学研究, 2013, 17(4): 359-363.
|
[14]
|
Mangiulli, M., Valletti, A., Caratozzolo, M.F., Tullo, A., Sbisà, E., Pesole, G., et al. (2009) Identification and Functional Characterization of Two New Transcriptional Variants of the Human p63 Gene. Nucleic Acids Research, 37, 6092-6104. https://doi.org/10.1093/nar/gkp674
|
[15]
|
Kawasaki, S., Tanioka, H., Yamasaki, K., Connon, C.J. and Kinoshita, S. (2006) Expression and Tissue Distribution of p63 Isoforms in Human Ocular Surface Pithelia. Experimental Eye Research, 82, 293-299.
https://doi.org/10.1016/j.exer.2005.07.001
|
[16]
|
Su, X., Chakravarti, D. and Flores, E.R. (2013) p63 Steps into the Limelight: Crucial Roles in the Suppression of Tumorigenesis and Metastasis. Nature Reviews Cancerr, 13, 136-143. https://doi.org/10.1038/nrc3446
|
[17]
|
袁丽丽, 李树峰, 严云勤. p53家族新成员p63基因[J]. 肿瘤学杂志, 2004, 10(6): 447-449.
|
[18]
|
Cervo, P.R., Lena, A.M., Nicoloso, M., Rossi, S., Mancini, M., Zhou, H., et al. (2012) p63-MicroRNA Feedback in Keratinocyte Senescence. Proceedings of the National Academy of Sciences of the United States of America, 109, 1133-1138. https://doi.org/10.1073/pnas.1112257109
|
[19]
|
Soares, E. and Zhou, H. (2018) Master Regulatory Role of p63 in Epidermal Development and Disease. Cellular and Molecular Life Science, 75, 1179-1190. https://doi.org/10.1007/s00018-017-2701-z
|
[20]
|
Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R., Bradley, A., et al. (1999) p63 Is a p53 Homologue Required for Limb and Epidermal Morphogenesis. Nature, 398, 708-713. https://doi.org/10.1038/19531
|
[21]
|
Mcgrath, J.A., Duijf, P.H., Doetseh, V., Irvine, A.D., de Waal, R., Vanmolkot, K.R., et al. (2001) Hay-Wells Syndromeis Caused by Heterozygous Missen-Mutations in the SAM Domain of p63. Human Molecular Genetics, 10, 221-229.
https://doi.org/10.1093/hmg/10.3.221
|
[22]
|
Ianakiev, P., Kilpatrick, M., Poudiarskai, W., Basel, D., Beighton, P. and Tsipouras, P. (2000) Splithand/Split-Foot Malformation Is Caused by Mutations in the p63 Gene on 3q27. The American Journal of Human Genetics, 67, 59-66.
https://doi.org/10.1086/302972
|
[23]
|
Westfall, M.D. and Pietenpol, J.A. (2004) P63: Molecular Complexity in Development and Cancer. Carcinogenesis, 25, 857-864. https://doi.org/10.1093/carcin/bgh148
|
[24]
|
Senoo, M., Pinto, F., Crum, C.P. and McKeon, F. (2007) p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia. Cell, 129, 523-536. https://doi.org/10.1016/j.cell.2007.02.045
|
[25]
|
咏梅, 赵诚. P63基因在口腔肿瘤中的研究进展[J]. 内蒙古医学院学报, 2012, 34(S6): 1006-1010.
|
[26]
|
Chompret, A. (2001) The Li-Fraumeni Syndrome. Biochimie, 84, 75-82.
https://doi.org/10.1016/S0300-9084(01)01361-X
|
[27]
|
Stanley, M. (2010) Pathology and Epidemiology of HPV Infection in Females. Gynecologic Oncology, 117, S5-S10.
https://doi.org/10.1016/j.ygyno.2010.01.024
|
[28]
|
Parish, J.L., Kowalczyk, A., Chen, H.T., Roeder, G.E., Sessions, R., Buckle, M., et al. (2006) E2 Proteins from High and Low Risk Human Papillomavirus Types Differ in Their Ability to Bind p53 and Induce Apoptotic Cell Death. Journal of Virology, 80, 4580-4590. https://doi.org/10.1128/JVI.80.9.4580-4590.2006
|
[29]
|
Martens, J.E., Arends, J., Van der Linden, P.J., De Boer, B.A. and Helmerhorst, T.J. (2004) Cytokeratin 17 and p63 Are Markers of the HPV Target Cell, the Cervical Stem Cell. Anticancer Research, 24, 771-775.
|
[30]
|
Quade, B.J., Yang, A., Wang, Y., Sun, D., Park, J., Sheets, E.E., et al. (2001) Expression of the p53 Homologue p63 in Early Cervical Neoplasia. Gynecologic Oncology, 80, 24-29. https://doi.org/10.1006/gyno.2000.5953
|
[31]
|
Houghton, O. and McCluggage, W.G. (2009) The Expression and Diagnostic Utility of p63 in the Female Genital Tract. Advances in Anatomic Pathology, 16, 316-321. https://doi.org/10.1097/PAP.0b013e3181b507c6
|
[32]
|
Garcia, M.T., Acar, B.C., Jorda, M., Gomez-Fernandez, C. and Ganjei-Azar, P. (2007) Use of p63 for Distinction of Glandular versus Squamous Lesions in Cervicovaginal Specimens. Cancer Cytopathology, 111, 54-57.
https://doi.org/10.1002/cncr.22419
|
[33]
|
Mitildzans, A., Arechvo, A., Rezeberga, D. and Isajevs, S. (2017) Ex-pression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia. Turkish Journal of Pathology, 33, 9-16. https://doi.org/10.5146/tjpath.2016.01373
|
[34]
|
Lin, Z.H., Liu, M.Z., Li, Z.H., Kim, C., Lee, E. and Kim, I. (2006) ΔNp63 Protein Expression in Uterine Cervical and Endometrial Cancers. Journal of Cancer Research and Clinical Oncology, 132, 811-816.
https://doi.org/10.1007/s00432-006-0130-8
|
[35]
|
Wang, T.Y., Chen, B.F., Yang, Y.C., Chen, H., Wang, Y., Cviko, A., Quade, B.J., Sun, D., Yang, A., McKeon, F.D. and Crum, C.P. (2001) Histologic and Immunophenotypic Classification of Cervical Carcinomas by Expression of the p53 Homologue p63: A Study of 250 Cases. Human Pa-thology, 32, 479-486. https://doi.org/10.1053/hupa.2001.24324
|
[36]
|
Melar-New, M. and Laimins, L.A. (2010) Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins. Journal of Virology, 84, 5212-5221.
https://doi.org/10.1128/JVI.00078-10
|
[37]
|
Mighty, K.K. and Laimins, L.A. (2011) p63 Is Necessary for the Ac-tivation of Human Papillomavirus Late Viral Functions upon Epithelial Differentiation. Journal of Virology, 85, 8863-8869. https://doi.org/10.1128/JVI.00750-11
|
[38]
|
Srivastava, K., Pickard, A., McDade, S. and McCance, D.J. (2017) p63 Drives Invasion in Keratinocytes Expressing HPV16 E6/E7 Genes through Regulation of Src-FAK Signalling. Oncotarget, 8, 16202-16219.
https://doi.org/10.18632/oncotarget.3892
|
[39]
|
Kurita, T., Mills, A.A. and Cunha, G.R. (2004) Roles of p63 in the Diethylstilbestrol-Induced Cervicovaginal Adenosis. Development, 131, 1639-1649. https://doi.org/10.1242/dev.01038
|
[40]
|
Allocati, N., Illo, C.D. and Laurenzi, V.D. (2012) p63/p73 in the Control of Cell Cycle and Cell Death. Experimental Cell Research, 318, 1285-1290. https://doi.org/10.1016/j.yexcr.2012.01.023
|
[41]
|
Teissier, S., Ben Khalifa, Y., Mori, M., Pautier, P., Desaintes, C. and Thierry, F. (2007) A New E6/P63 Pathway, Together with a Strong E7/E2F Mitotic Pathway, Modulates the Transcriptome in Cervical Cancer Cells. Journal of Virology, 81, 9368-9376. https://doi.org/10.1128/JVI.00427-07
|
[42]
|
Lin, Z., Nan, Y., Zhang, X., Zhao, Y., Kim, C. and Kim, I. (2006) Reverse Transcription-Polymerase Chain Reaction and Western Blotting Analysis for Detection of p63 Isoforms in Uterine Cervical Cancers. International Journal of Gynecological Cancer, 16, 1643-1647.
|
[43]
|
Liu, X., Clements, A., Zhao, K. and Marmorstein, R. (2006) Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor. Journal of Biological Chemistry, 281, 578-586. https://doi.org/10.1074/jbc.M508455200
|
[44]
|
Dyson, N. (1998) The Regulation of E2F by pRB-Family Proteins. Genes & Development, 12, 2245-2262.
https://doi.org/10.1101/gad.12.15.2245
|